Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,156 GBX | -0.43% | -0.70% | +9.66% |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.95B | Sales 2025 * | 4.27B 5.43B | Capitalization | 3.99B 5.07B |
---|---|---|---|---|---|
Net income 2024 * | 469M 596M | Net income 2025 * | 504M 641M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
8.55
x | P/E ratio 2025 * |
7.85
x | Employees | 3,000 |
Yield 2024 * |
2.78% | Yield 2025 * |
3.08% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
1 day | -0.51% | ||
1 week | -0.17% | ||
Current month | -5.61% | ||
1 month | -1.11% | ||
3 months | +9.53% | ||
6 months | +15.52% | ||
Current year | +10.15% |
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 746 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1,155 | -0.52% | 88 031 |
24-05-20 | 1,161 | -0.51% | 529,452 |
24-05-17 | 1,167 | -1.27% | 668,193 |
24-05-16 | 1,182 | +1.81% | 457,949 |
24-05-15 | 1,161 | -0.26% | 427,531 |
Delayed Quote London S.E., May 20, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.15% | 5.07B | |
+44.18% | 62.4B | |
+16.30% | 52.29B | |
+13.18% | 49.37B | |
+19.92% | 44.3B | |
+34.87% | 37.46B | |
+12.64% | 30.08B | |
+70.45% | 28.2B | |
+26.88% | 25.7B | |
+1.72% | 21.96B |
- Stock Market
- Equities
- HSX Stock